{
 "PrintNo":"A3935","Session":2021,"Chamber":"ASSEMBLY","BillType":"Assembly","Published":"2021-01-29T15:46:33.7206Z",
 "Status":"STRICKEN","Milestones":[{"Type":"IN_ASSEMBLY_COMM","Date":"2022-01-05","Committee":"Insurance"}],
 "Actions":[
  {"Text":"REFERRED TO INSURANCE","Date":"2021-01-29","Chamber":"ASSEMBLY"},
  {"Text":"REFERRED TO INSURANCE","Date":"2022-01-05","Chamber":"ASSEMBLY"},
  {"Text":"ENACTING CLAUSE STRICKEN","Date":"2022-03-21","Chamber":"ASSEMBLY"}
 ],
 "Sponsors":[{"ID":1115,"Name":"Melissa Miller","Short":"MILLER M"}],"Title":"Relates to off-label drug usage",
 "Summary":"Requires insurers and pharmacy benefit managers provide coverage for off-label drug usage in certain circumstances.",
 "LawSection":"Insurance Law","LawCode":"Add ยง3114, Ins L; amd ยง280-a, Pub Health L",
 "ActClause":"AN ACT to amend the insurance law and the public health law, in relation to off-label drug usage",
 "PreviousVersions":["A9115-2019"]
}